- 5 September 2025[PDF; 167 kB]
Advancing Preoperative Diagnostics of Metastatic Lung Cancer - 5 March 2025[PDF; 120 kB]
Big Leap Toward Improved Diagnosis and Treatment Monitoring of Lung Fibrosis - 24 May 2024[PDF; 115 kB]
Hope for the Diagnosis and Treatment of Cancer and Brain Metastases - 11 April 2024[PDF; 128 kB]
Phase 2 study interim report presented at the Annual Congress of the German Society of Nuclear Medicine - 10 July 2023[PDF; 112 kB]
TRIMT GmbH achieves impressive success in the competition for Saxon State Prizes - 10 October 2022[PDF; 224 kB]
Press Release: 18F-Flutrahexin is on the way, built on Nobel Prize awarded Click Chemistry technology! - 29 September 2022[Youtube]
Media published: Interview with Trivehexin's inventors Dr. Johannes Notni and Neil Quigley - 27 September 2022[PDF; 152 kB]
Press release: Ga-68-Trivehexin in PDAC presented at the EANM's TOP Trial Sessions - 31 August 2022[Youtube]
Media published: Dr. Jakub Simecek discussing the TRIMT technology, start-up scene and leadership in biotech with Matt Grady - 27 June 2022[PDF; 628 kB]
Media published: Poster on Ga-68-Trivehexin presented at 6th WTC in Wiesbaden - 28 April 2022[PDF; 116 kB]
Press Release: Georg von Hevesy-Prize 2022 - 10 January 2022[PDF; 124 kB]
Press Release: TRIMT and Eckert & Ziegler enter service agreement - 17 August 2021[PDF; 144 kB]
Press Release: Radiopharm Thernostics entered into an exclusive license agreement with TRIMT - 31 May 2021[PDF; 112 kB]
Press Release: BayPAT entered into an exclusive license agreement with TRIMT